Newly Effective HIPAA Omnibus Rule Makes Sweeping Changes to HIPAA

by Smith Anderson

The long-awaited final omnibus rule (Omnibus Rule) that modifies the Health Insurance Portability and Accountability Act of 1996 (HIPAA) [1] took effect last week, on March 26, 2013. Leon Rodriguez, Director of the U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR) calls the changes the “most sweeping” since the HIPAA Privacy and Security Rules were first implemented. Among the changes is an enhanced opportunity for OCR to enforce compliance. HIPAA covered entities and business associates generally have 6 months – until September 23, 2013 – to become compliant with the Omnibus Rule.

Who do the Changes Affect?

  • HIPAA covered entities, including health care providers, health systems, health plans (including insured and most self-insured employer group health plans) and clearinghouses.
  • HIPAA business associates, including a wide range of vendors who contract with covered entities and access protected health information (PHI). Examples include technology vendors, services organizations, accountable care organizations (ACOs), and third party administrators.

What Action is Required?

HIPAA covered entities and business associates should act now to take the following measures:

  • Revise Business Associate Agreement template forms;
  • Evaluate existing contractor arrangements to determine whether modifications or new agreement provisions are necessary, including to existing Business Associate Agreements;
  • Revise HIPAA Policies and Procedures, including modifications to address response to potential breaches involving unsecured PHI;
  • Update and redistribute Notices of Privacy Practices;
  • Analyze current arrangements for compliance with restrictions on the sale of PHI, and marketing and fundraising restrictions; and
  • Train employees on updated obligations.

Some of the Key Changes Under the Omnibus Rule Include:

Definition of Business Associate Expanded. The Omnibus Rule expands the definition of business associate to include:

  • Any downstream subcontractor that creates, receives, maintains, or transmits PHI on behalf of the business associate, even if they have an indirect relationship with a covered entity;
  • Health information organizations, e-prescribing gateways, or other persons that provide data transmission services to a covered entity that require routine access to PHI; and
  • Any person that offers a personal health record to individuals on behalf of a covered entity.

Covered entities and business associates will want to evaluate existing arrangements to determine whether a Business Associate Agreement is required or modifications to existing agreements are necessary.

Liability and Obligations of Business Associates Expanded. The Omnibus Rule expands the liability and obligations of business associates, such that:

  • Business associates and their subcontractors who have access to PHI are directly liable for compliance with the HIPAA Privacy and Security Rules, and thus, may be assessed civil monetary penalties and criminal penalties for violations;
  • Business associates and their direct subcontractors that access PHI must enter compliant Business Associate Agreements all the way “down the chain” of the information flow; and
  • Business Associate Agreements must be updated to include specific new provisions; however, existing Business Associate Agreements entered before January 25, 2013 that are compliant with the interim rules may operate until the agreement is amended or renewed, or until September 22, 2014, whichever is earlier.

Covered entities and business associates will want to modify their business associate agreement forms not only to include new legal requirements, but also to allocate risk through the use of insurance requirements and indemnity provisions.

Revised Breach Notification Standard. The Omnibus Rule eliminates the “significant risk of harm” standard as the threshold for breach notification.

  • Under the previous rule, breaches were not required to be reported unless they posed a “significant risk of reputational, financial or other harm” to individuals. The new standard presumes that a reportable breach has occurred unless the covered entity or business associate, through the use of a multi-factor risk assessment, determines that there is a low probability that the PHI has been compromised by the unauthorized use or disclosure.

Covered entities and business associates will want to revise their breach notice policies and procedures to reflect this new breach analysis standard.  

Marketing, Fundraising, and the Sale of PHI.

  • Marketing: The Omnibus Rule imposes stricter limitations on marketing communications made in exchange for financial remuneration. Specifically, written communications promoting purchase or use of a third party’s products or services require prior individual authorization if the covered entity receives financial remuneration in exchange for sending the communication. Limited exceptions exist to permit face-to-face marketing communications, certain promotional gifts and refill reminders so long as the remuneration is reasonably related to the cost of the communication.
  • Fundraising: The Omnibus Rule provides a limited set of circumstances in which a covered entity can use and disclose certain PHI for fundraising without an authorization.  Regardless of whether an authorization for fundraising was required or obtained, covered entities must provide an individual with a clear and conspicuous opportunity to opt-out of receiving future fundraising communications.
  • Sale of PHI: The Omnibus Rule prohibits the sale of PHI unless the individual has authorized it. The requisite authorization must acknowledge that the covered entity will receive remuneration in exchange for PHI.

Covered entities and business associates will want to analyze arrangements for compliance with these marketing, fundraising and sale of PHI restrictions.

Changes to Enforcement Rules.

  • HHS may impose civil monetary penalties up to $1.5 million for all violations of an identical HIPAA requirement in a calendar year.
  • The Omnibus Rule eliminates an exception under the previous rule that shielded covered entities from civil penalties stemming from the conduct of their business associates if certain conditions were met. Under the Omnibus Rule, covered entities and business associates are liable for the acts of their respective business associate agents.  Whether a business associate is an agent is based on the Federal common law of agency and depends on the principal’s right or authority to control the business associate’s conduct in the course of performing services. Covered entities and business associates should consider how best to allocate risk related to any agency relationship through the use of indemnity provisions in the underlying services agreement or their Business Associate Agreement.
  • The Omnibus Rule eliminates HHS’s discretion in choosing whether to investigate complaints or potential violations in cases where HHS’s preliminary review reveals a possible violation due to willful neglect. HHS is required to initiate a formal investigation when a party appears to have exhibited willful neglect.

Other Notable Changes.

  • Covered entities must change their Notices of Privacy Practices to describe certain uses and disclosures of PHI and redistribute such notices to patients.
  • The Omnibus Rule gives individuals the right to have their provider restrict certain PHI from disclosure to health plans where the individual pays for the care out-of-pocket in full and requests such a restriction.
  • The Omnibus Rule prohibits health plans from using or disclosing genetic information for underwriting purposes, as required by the Genetic Information Nondiscrimination Act.

This Client Alert does not include a full summary of all changes implemented by the Omnibus Rule. For the full rule text, click here. To discuss how these or any other changes provided by the Omnibus Rule may apply to your organization, please contact us.

[1] Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules under the Health Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules, 78 Fed. Reg. 5566 (Jan. 25, 2013) (to be codified at 45 C.F.R. Parts 160 and 164).

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Smith Anderson | Attorney Advertising

Written by:

Smith Anderson

Smith Anderson on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.